Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 350

1.

Angioimmunoblastic lymphadenopathy with dysproteinemia following doxycycline administration.

Batinac T, Zamolo G, Jonjić N, Gruber F, Nacinović A, Seili-Bekafigo I, Coklo M.

Tumori. 2003 Jan-Feb;89(1):91-5.

PMID:
12729371
2.

Cutaneous involvement by angioimmunoblastic T-cell lymphoma with remarkable heterogeneous Epstein-Barr virus expression.

Brown HA, Macon WR, Kurtin PJ, Gibson LE.

J Cutan Pathol. 2001 Sep;28(8):432-8.

PMID:
11493382
3.

[Angioblastic lymphadenopathy--its course and prognosis].

Mihaljević B, Jancić-Nedeljkov R, Janković S, Milivojević G, Cemerikić-Martinović V, Jovanović V, Colović M, Petrović M.

Srp Arh Celok Lek. 1999 Nov-Dec;127(11-12):376-82. Serbian.

PMID:
10686819
4.
5.

Angioimmunoblastic lymphadenopathy with dysproteinemia: emphasis on pathogenesis and treatment.

Sallah S, Gagnon GA.

Acta Haematol. 1998;99(2):57-64. Review.

PMID:
9554450
6.
7.

Cutaneous involvement in prelymphomatous angioimmunoblastic lymphadenopathy.

Schmuth M, Ramaker J, Trautmann C, Hummel M, Schmitt-Gräff A, Stein H, Goerdt S.

J Am Acad Dermatol. 1997 Feb;36(2 Pt 2):290-5.

PMID:
9039203
8.

Clinicopathologic, immunophenotypic, and immunogenotypic analyses of immunoblastic lymphadenopathy-like T-cell lymphoma.

Tobinai K, Minato K, Ohtsu T, Mukai K, Kagami Y, Miwa M, Watanabe S, Shimoyama M.

Blood. 1988 Sep;72(3):1000-6.

9.
10.

Angioimmunoblastic lymphadenopathy with dysproteinemia--lack of a prognostic value of clear cell morphology.

Ch'ang HJ, Su IJ, Chen CL, Chiang IP, Chen YC, Wang CH, Cheng AL.

Oncology. 1997 May-Jun;54(3):193-8.

PMID:
9143398
11.

[Seropositive polyarthritis as a presentation form of angioimmunoblastic lymphadenopathy].

Bistué R, Scognamillo C, Lovato G, Parra G, Maddio J, Roselli G.

Medicina (B Aires). 1993;53(5):435-8. Spanish.

PMID:
8201932
12.

[Angioimmunoblastic lymphadenopathy with cutaneous manifestations in a 13-year-old girl].

Schotte U, Megahed M, Jansen T, Rübo J, Vandieken R, Goerz G, Plewig G.

Hautarzt. 1992 Nov;43(11):728-34. German.

PMID:
1281812
14.

Cutaneous involvement in patients with angioimmunoblastic lymphadenopathy with dysproteinemia: a clinical, immunohistological, and molecular analysis.

Martel P, Laroche L, Courville P, Larroche C, Wechsler J, Lenormand B, Delfau MH, Bodemer C, Bagot M, Joly P.

Arch Dermatol. 2000 Jul;136(7):881-6.

PMID:
10890990
15.

[Angioimmunoblastic lymphadenopathy. 8 cases and review of the literature].

Dubas JM, Widgren S, Zwahlen A.

Schweiz Med Wochenschr. 1978 Aug 26;108(34):1295-302. Review. French.

PMID:
358386
16.

Angioimmunoblastic lymphadenopathy.

Su WP.

Dermatol Clin. 1985 Oct;3(4):759-68. Review.

PMID:
3916179
17.

Angioimmunoblastic lymphadenopathy (AILD) with benign course.

Mihaljević B, Donfrid M, Jancić-Nedeljkov R, Jovanović V, Petrović M.

Haematologia (Budap). 1996;28(1):21-5.

PMID:
9283900
18.
19.

NIH conference. Angioimmunoblastic lymphadenopathy with dysproteinemia.

Steinberg AD, Seldin MF, Jaffe ES, Smith HR, Klinman DM, Krieg AM, Cossman J.

Ann Intern Med. 1988 Apr;108(4):575-84. Review.

PMID:
3279895
20.

A case of angio-immunoblastic lymphadenopathy with dysproteinemia related to allopurinol.

Irino S, Sanada H, Maesako N, Tanaka T.

Acta Med Okayama. 1981 Oct;35(4):263-72.

PMID:
6457513
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk